The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EGRX | +42.86% | -97.89% | -53.8% | -92% |
| S&P | +15.06% | +95.03% | +14.29% | +270% |
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Great stocks for smart investors can be found in different corners of the market.
Acadia Pharmaceuticals, Regeneron Pharmaceuticals, and Eagle Pharmaceuticals all look like solid choices for the year ahead.
Currently no data to display
Currently no data to display.
Currently no data to display.
| Metric | YoY Change |
|---|
EGRX earnings call for the period ending June 30, 2022.
EGRX earnings call for the period ending March 31, 2022.
EGRX earnings call for the period ending December 31, 2021.
EGRX earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
